SUPPLEMENT

Q1 2024 — Income statement trends

Q1 2024PDF · 2 pages144 KB
CME GROUP INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF GAAP INCOME
QUARTER ENDED
(dollars in millions, except per share data; shares in thousands)
Q122 	Q222 	Q322 	Q422 	Q123 	Q223 	Q323 	Q423 	Q124
Revenues:
Clearing and transaction fees 	1,138.1 	1,024.6 	998.6 	981.4 	1,200.2 	1,118.3 	1,085.5 	1,184.5 	1,208.9
Market data and information services 	151.7 	151.7 	154.3 	153.2 	165.8 	163.1 	167.6 	167.2 	175.4
Other Revenue 	56.8 	60.9 	74.9 	73.2 	75.6 	78.8 	84.7 	87.6 	103.6
Total revenues 	1,346.6 	1,237.2 	1,227.8 	1,207.8 	1,441.6 	1,360.2 	1,337.8 	1,439.3 	1,487.9
Expenses:
Compensation and benefits 	185.2 	185.3 	189.6 	193.0 	204.5 	205.7 	205.5 	212.9 	206.0
Technology 	45.9 	45.9 	46.8 	50.0 	51.3 	53.3 	55.6 	58.5 	59.4
Professional fees and outside services 	31.8 	32.0 	35.1 	38.5 	38.3 	37.8 	32.2 	36.1 	33.1
Amortization of purchased intangibles 	58.4 	57.1 	55.5 	56.7 	56.8 	57.0 	57.2 	55.6 	55.2
Depreciation and amortization 	33.5 	33.0 	34.5 	33.9 	31.9 	32.3 	31.1 	30.7 	30.1
Licensing and other fee agreements 	80.9 	83.1 	83.6 	72.4 	84.7 	78.2 	79.5 	80.4 	87.9
Other expense 	51.8 	51.1 	43.9 	95.0 	60.4 	57.3 	56.5 	101.9 	56.6
Operating expenses 	487.5 	487.5 	489.0 	539.5 	527.9 	521.6 	517.6 	576.1 	528.3
Operating Income 	859.1 	749.7 	738.8 	668.3 	913.7 	838.6 	820.2 	863.2 	959.6
Operating Margin 	64% 	61% 	60% 	55% 	63% 	62% 	61% 	60% 	64%
Non-operating Income and Expense
Investment income 	73.1 	286.9 	686.2 	1,152.2 	1,357.7 	1,568.2 	1,272.5 	1,076.9 	1,071.3
Interest and other borrowing costs 	(42.5) 	(39.9) 	(40.4) 	(39.9) 	(39.9) 	(40.2) 	(39.6) 	(39.7) 	(39.9)
Equity in net gains (losses) of unconsolidated subsidiaries 	73.3 	87.3 	76.5 	64.0 	78.2 	75.1 	76.8 	66.8 	87.2
Other non-operating income (expense) 	(46.7) 	(217.3) 	(581.1) 	(1,017.3) 	(1,152.8) 	(1,425.3) 	(1,155.6) 	(961.2) 	(964.8)
Non-operating income (expense) 	57.2 	117.0 	141.2 	159.0 	243.2 	177.8 	154.1 	142.8 	153.8
Income before income taxes 	916.3 	866.7 	880.0 	827.3 	1,156.9 	1,016.4 	974.3 	1,006.0 	1,113.4
Income taxes 	205.3 	204.2 	200.4 	189.4 	273.1 	238.8 	224.1 	191.4 	258.2
Net income 	711.0 	662.5 	679.6 	637.9 	883.8 	777.6 	750.2 	814.6 	855.2
Less: net income (loss) attributable to NCI 	- 	- 	- 	- 	- 	- 	- 	- 	-
Net Income Attributable to CME Group 	711.0 	662.5 	679.6 	637.9 	883.8 	777.6 	750.2 	814.6 	855.2
Net Income Attributable to Common Shareholders of CME Group 	702.0 	654.1 	671.1 	629.9 	872.7 	767.8 	740.8 	804.3 	844.4
Effective Tax Rate 	22.4% 	23.6% 	22.8% 	22.8% 	23.6% 	23.5% 	23.0% 	19.0% 	23.2%
Earnings per Share Attributable to Common Shareholders of CME Group:
Basic EPS 	1.96 	1.82 	1.87 	1.76 	2.43 	2.14 	2.06 	2.24 	2.35
Diluted EPS 	1.95 	1.82 	1.87 	1.75 	2.43 	2.14 	2.06 	2.24 	2.35
Weighted average number of common stock shares:
Basic Shares 	358,609 	358,641 	358,715 	358,885 	358,933 	358,940 	359,020 	359,197 	359,258
Diluted Shares 	359,180 	359,205 	359,288 	359,190 	359,313 	359,429 	359,619 	359,693 	359,833
Preferred Shares 	4,584 	4,584 	4,584 	4,584 	4,584 	4,584 	4,584 	4,584 	4,584

-- 1 of 2 --

CME GROUP INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF NON-GAAP INCOME
QUARTER ENDED
(dollars in millions, except per share data; shares in thousands)
Q122 	Q222 	Q322 	Q422 	Q123 	Q223 	Q323 	Q423 	Q124
Revenues:
Clearing and transaction fees 	1,138.1 	1,024.6 	998.6 	981.4 	1,200.2 	1,118.3 	1,085.5 	1,184.5 	1,208.9
Market data and information services 	151.7 	151.7 	154.3 	153.2 	165.8 	163.1 	167.6 	167.2 	175.4
Other Revenue 	56.8 	60.9 	74.9 	73.2 	75.6 	78.8 	84.7 	87.6 	103.6
Total revenues 	1,346.6 	1,237.2 	1,227.8 	1,207.8 	1,441.6 	1,360.2 	1,337.8 	1,439.3 	1,487.9
Expenses:
Compensation and benefits 	182.8 	189.5 	189.1 	184.6 	192.8 	194.4 	193.5 	204.4 	196.1
Technology 	45.8 	45.9 	46.8 	50.0 	51.3 	53.3 	55.6 	58.5 	59.4
Professional fees and outside services 	30.3 	31.4 	35.1 	38.5 	38.3 	37.8 	32.2 	36.1 	33.1
Amortization of purchased intangibles 	- 	- 	- 	- 	- 	- 	- 	- 	-
Depreciation and amortization 	33.5 	32.9 	33.8 	33.9 	31.9 	31.8 	31.1 	29.8 	29.3
Licensing and other fee agreements 	80.9 	83.1 	81.9 	72.4 	84.7 	78.2 	79.5 	80.4 	87.9
Other expense 	51.7 	59.6 	54.4 	84.5 	59.7 	56.2 	56.5 	80.3 	56.5
Operating expenses 	425.0 	442.4 	441.1 	463.9 	458.7 	451.7 	448.4 	489.5 	462.3
Operating Income 	921.6 	794.8 	786.7 	743.9 	982.9 	908.5 	889.4 	949.8 	1,025.6
Operating Margin 	68% 	64% 	64% 	62% 	68% 	67% 	66% 	66% 	69%
Non-operating Income and Expense
Investment income 	74.7 	299.5 	688.5 	1,147.1 	1,277.5 	1,564.0 	1,276.6 	1,068.5 	1,061.7
Interest and other borrowing costs 	(42.5) 	(39.9) 	(40.4) 	(39.9) 	(39.9) 	(40.2) 	(39.6) 	(39.7) 	(39.9)
Equity in net gains (losses) of unconsolidated subsidiaries 	84.7 	98.2 	89.6 	76.2 	91.5 	88.6 	90.4 	85.1 	100.7
Other non-operating income (expense) 	(43.4) 	(218.5) 	(585.7) 	(1,023.3) 	(1,160.6) 	(1,429.9) 	(1,157.1) 	(958.8) 	(964.8)
Non-operating income (expense) 	73.5 	139.3 	152.0 	160.1 	168.5 	182.5 	170.3 	155.1 	157.7
Income before income taxes 	995.1 	934.1 	938.7 	904.0 	1,151.4 	1,091.0 	1,059.7 	1,104.9 	1,183.3
Income taxes 	228.9 	217.6 	219.6 	206.0 	269.1 	254.6 	241.7 	240.2 	272.2
Net income 	766.2 	716.5 	719.1 	698.0 	882.3 	836.4 	818.0 	864.7 	911.1
Less: net income (loss) attributable to NCI 	- 	- 	- 	- 	- 	- 	- 	- 	-
Net Income Attributable to CME Group 	766.2 	716.5 	719.1 	698.0 	882.3 	836.4 	818.0 	864.7 	911.1
Net Income Attributable to Common Shareholders of CME Group 	756.6 	707.5 	710.0 	689.1 	871.1 	825.9 	807.9 	853.8 	899.7
Effective Tax Rate 	23.0% 	23.3% 	23.4% 	22.8% 	23.4% 	23.3% 	22.8% 	21.7% 	23.0%
Earnings per Share Attributable to Common Shareholders of CME Group:
Basic EPS 	2.11 	1.97 	1.98 	1.92 	2.43 	2.30 	2.25 	2.38 	2.50
Diluted EPS 	2.11 	1.97 	1.98 	1.92 	2.42 	2.30 	2.25 	2.37 	2.50
Weighted average number of common stock shares:
Basic Shares 	358,609 	358,641 	358,715 	358,885 	358,933 	358,940 	359,020 	359,197 	359,258
Diluted Shares 	359,180 	359,205 	359,288 	359,190 	359,313 	359,429 	359,619 	359,693 	359,833
Preferred Shares 	4,584 	4,584 	4,584 	4,584 	4,584 	4,584 	4,584 	4,584 	4,584

-- 2 of 2 --